Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation

Lijian Shao, Yan Sun, Zhonghui Zhang, Wei Feng, Yongxing Gao, Zailong Cai, Zack Z. Wang, A. Thomas Look, Wen Shu Wu

Research output: Contribution to journalArticle

Abstract

Bone marrow injury is a major adverse side effect of radiation and chemotherapy. Attempts to limit such damage are warranted, but their success requires a better understanding of how radiation and anticancer drugs harm the bone marrow. Here, we report one pivotal role of the BH3-only protein Puma in the radiosensitivity of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs). Puma deficiency in mice confers resistance to high-dose radiation in a hematopoietic cell-autonomous manner. Unexpectedly, loss of one Puma allele is sufficient to confer mice radioresistance. Interestingly, null mutation in Puma protects both primitive and differentiated hematopoietic cells from damage caused by low-dose radiation but selectively protects HSCs and HPCs against high-dose radiation, thereby accelerating hematopoietic regeneration. Consistent with these findings, Puma is required for radiation-induced apoptosis in HSCs and HPCs, and Puma is selectively induced by irradiation in primitive hematopoietic cells, and this induction is impaired in Puma-heterozygous cells. Together, our data indicate that selective targeting of p53 downstream apoptotic targets may represent a novel strategy to protecting HSCs and HPCs in patients undergoing intensive cancer radiotherapy and chemotherapy.

Original languageEnglish (US)
Pages (from-to)4707-4714
Number of pages8
JournalBlood
Volume115
Issue number23
DOIs
StatePublished - Jun 10 2010
Externally publishedYes

Fingerprint

Puma
Hematopoietic Stem Cells
Stem cells
Dosimetry
Radiation
Chemotherapy
Bone
Radiotherapy
Bone Marrow
Irradiation
Apoptosis
Drug Therapy
Radiation Tolerance
Radiation Effects
Pharmaceutical Preparations
Regeneration
Proteins
Alleles
Mutation

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. / Shao, Lijian; Sun, Yan; Zhang, Zhonghui; Feng, Wei; Gao, Yongxing; Cai, Zailong; Wang, Zack Z.; Look, A. Thomas; Wu, Wen Shu.

In: Blood, Vol. 115, No. 23, 10.06.2010, p. 4707-4714.

Research output: Contribution to journalArticle

Shao, Lijian ; Sun, Yan ; Zhang, Zhonghui ; Feng, Wei ; Gao, Yongxing ; Cai, Zailong ; Wang, Zack Z. ; Look, A. Thomas ; Wu, Wen Shu. / Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. In: Blood. 2010 ; Vol. 115, No. 23. pp. 4707-4714.
@article{8f92538dd94c48fa9a5da347fb4f15ed,
title = "Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation",
abstract = "Bone marrow injury is a major adverse side effect of radiation and chemotherapy. Attempts to limit such damage are warranted, but their success requires a better understanding of how radiation and anticancer drugs harm the bone marrow. Here, we report one pivotal role of the BH3-only protein Puma in the radiosensitivity of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs). Puma deficiency in mice confers resistance to high-dose radiation in a hematopoietic cell-autonomous manner. Unexpectedly, loss of one Puma allele is sufficient to confer mice radioresistance. Interestingly, null mutation in Puma protects both primitive and differentiated hematopoietic cells from damage caused by low-dose radiation but selectively protects HSCs and HPCs against high-dose radiation, thereby accelerating hematopoietic regeneration. Consistent with these findings, Puma is required for radiation-induced apoptosis in HSCs and HPCs, and Puma is selectively induced by irradiation in primitive hematopoietic cells, and this induction is impaired in Puma-heterozygous cells. Together, our data indicate that selective targeting of p53 downstream apoptotic targets may represent a novel strategy to protecting HSCs and HPCs in patients undergoing intensive cancer radiotherapy and chemotherapy.",
author = "Lijian Shao and Yan Sun and Zhonghui Zhang and Wei Feng and Yongxing Gao and Zailong Cai and Wang, {Zack Z.} and Look, {A. Thomas} and Wu, {Wen Shu}",
year = "2010",
month = "6",
day = "10",
doi = "10.1182/blood-2009-10-248872",
language = "English (US)",
volume = "115",
pages = "4707--4714",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "23",

}

TY - JOUR

T1 - Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation

AU - Shao, Lijian

AU - Sun, Yan

AU - Zhang, Zhonghui

AU - Feng, Wei

AU - Gao, Yongxing

AU - Cai, Zailong

AU - Wang, Zack Z.

AU - Look, A. Thomas

AU - Wu, Wen Shu

PY - 2010/6/10

Y1 - 2010/6/10

N2 - Bone marrow injury is a major adverse side effect of radiation and chemotherapy. Attempts to limit such damage are warranted, but their success requires a better understanding of how radiation and anticancer drugs harm the bone marrow. Here, we report one pivotal role of the BH3-only protein Puma in the radiosensitivity of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs). Puma deficiency in mice confers resistance to high-dose radiation in a hematopoietic cell-autonomous manner. Unexpectedly, loss of one Puma allele is sufficient to confer mice radioresistance. Interestingly, null mutation in Puma protects both primitive and differentiated hematopoietic cells from damage caused by low-dose radiation but selectively protects HSCs and HPCs against high-dose radiation, thereby accelerating hematopoietic regeneration. Consistent with these findings, Puma is required for radiation-induced apoptosis in HSCs and HPCs, and Puma is selectively induced by irradiation in primitive hematopoietic cells, and this induction is impaired in Puma-heterozygous cells. Together, our data indicate that selective targeting of p53 downstream apoptotic targets may represent a novel strategy to protecting HSCs and HPCs in patients undergoing intensive cancer radiotherapy and chemotherapy.

AB - Bone marrow injury is a major adverse side effect of radiation and chemotherapy. Attempts to limit such damage are warranted, but their success requires a better understanding of how radiation and anticancer drugs harm the bone marrow. Here, we report one pivotal role of the BH3-only protein Puma in the radiosensitivity of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs). Puma deficiency in mice confers resistance to high-dose radiation in a hematopoietic cell-autonomous manner. Unexpectedly, loss of one Puma allele is sufficient to confer mice radioresistance. Interestingly, null mutation in Puma protects both primitive and differentiated hematopoietic cells from damage caused by low-dose radiation but selectively protects HSCs and HPCs against high-dose radiation, thereby accelerating hematopoietic regeneration. Consistent with these findings, Puma is required for radiation-induced apoptosis in HSCs and HPCs, and Puma is selectively induced by irradiation in primitive hematopoietic cells, and this induction is impaired in Puma-heterozygous cells. Together, our data indicate that selective targeting of p53 downstream apoptotic targets may represent a novel strategy to protecting HSCs and HPCs in patients undergoing intensive cancer radiotherapy and chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=77954709903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954709903&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-10-248872

DO - 10.1182/blood-2009-10-248872

M3 - Article

C2 - 20360471

AN - SCOPUS:77954709903

VL - 115

SP - 4707

EP - 4714

JO - Blood

JF - Blood

SN - 0006-4971

IS - 23

ER -